- Lobbying
- Lauren AND Reliford
Lobbying Arrangements Results for 'Lauren Reliford'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Pharmacy reimbursement issues |
Senior Care Pharmacy Alliance
|
VENN STRATEGIES, LLC | |||
Details Pharmacy reimbursement issues |
Senior Care Pharmacy Coalition
|
VENN STRATEGIES, LLC | |||
Details Pharmacy reimbursement issues |
Managed Health Care Associates, Inc.
|
VENN STRATEGIES, LLC | |||
Details Advocacy related to safety of vision therapies. |
Safe Vision Alliance
|
VENN STRATEGIES, LLC | |||
Details General health issues relating to patient transitions of care |
National Transitions of Care Coalition
|
VENN STRATEGIES, LLC | |||
Details Laws and policies affecting health care and group purchasing organizations |
AMERINET, INC
|
VENN STRATEGIES, LLC | |||
Details Orphan drugs and rare diseases, matters related to drug reimbursement policy. Orphan drugs and rare disease matters |
BioMarin Pharmaceutical, Inc.
|
VENN STRATEGIES | |||
Details Health care issues related to home dialysis services. Medicare coverage of home dialysis for acute kidney injury patients. |
Alliance for Home Dialysis
|
VENN STRATEGIES | |||
Details General issues related to policy to prevent and treat U.S. obesity. General Issues related to policy to prevent and treat U.S. obesity. |
Campaign to End Obesity Action Fund
|
VENN STRATEGIES | |||
Details Legislation and other proposed policy change impacting S Corporation ESOPs. |
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA
|
VENN STRATEGIES | |||
Details General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response. Measures related to U.S. international and corpor... |
Regeneron Pharmaceuticals, Inc.
|
VENN STRATEGIES | |||
Details FY 2024 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R.5894, S.2624): NIH, CDC, AHRQ funding and report language; palliative care research funding; Department... |
American Heart Association
|
in-house lobbying |